| Literature DB >> 19502905 |
Kitty Kit Ting Cheung1, Kai Ming Chow, Cheuk Chun Szeto, Morris Hok Leung Tai, Bonnie Ching Ha Kwan, Philip Kam Tao Li.
Abstract
We report a 56-year-old male hemodialysis patient who developed fatal pancytopenia after treatment with low-dose methotrexate for psoriasis and psoriatic arthropathy. Risk factors identified included impaired renal function, concurrent use of nonsteroidal anti-inflammatory drugs, low serum albumin, and relatively low serum folate level. Literature review found similar risk factors in 12 other cases. Therefore, methotrexate, even as a single dose, should not be used to treat rheumatic conditions in dialysis patients.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19502905 DOI: 10.1097/RHU.0b013e3181a61f2d
Source DB: PubMed Journal: J Clin Rheumatol ISSN: 1076-1608 Impact factor: 3.517